Difference between Enbrel and Benepali treatment groups in 'hepatobiliary disorders'

Ann Rheum Dis. 2016 Oct;75(10):e64. doi: 10.1136/annrheumdis-2016-210101. Epub 2016 Jul 18.

Authors

Morton Scheinberg¹, Valderilio Azevedo²

Affiliations

¹ Section of Rheumatology-Orthopedics, Hospital Israelita Albert Einstein, São Paulo, Brazil.
² Rheumatology Section, Universidade Federal do Parana, Rebouças-Paraná, Brazil.

PMID: 27432354
DOI: 10.1136/annrheumdis-2016-210101

No abstract available

Keywords: Anti-TNF; Cytokines; Early Rheumatoid Arthritis.

Publication types

Letter
Comment

MeSH terms

Antirheumatic Agents
Arthritis, Rheumatoid
Etanercept*
Receptors, Tumor Necrosis Factor*
Tumor Necrosis Factor-alpha

Substances

Antirheumatic Agents
Receptors, Tumor Necrosis Factor
Tumor Necrosis Factor-alpha
Etanercept